Evaluation of blood-based PRO-C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta-analysis.

Journal of gastroenterology and hepatology(2023)

引用 0|浏览4
暂无评分
摘要
PRO-C3 demonstrated clinically meaningful diagnostic accuracy when used alone as a non-invasive biomarker for diagnosing the liver fibrosis stage in individuals with viral hepatitis or fatty liver disease.
更多
查看译文
关键词
chronic liver disease, liver fibrosis, meta-analysis, non-invasive biomarker, PRO-C3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要